tiprankstipranks
Arcutis Biotherapeutics announces new patient-reported data on ZORYVE
PremiumThe FlyArcutis Biotherapeutics announces new patient-reported data on ZORYVE
2M ago
Arcutis Biotherapeutics receives Health Canada approval of ZORYVE Foam 0.3%
Premium
The Fly
Arcutis Biotherapeutics receives Health Canada approval of ZORYVE Foam 0.3%
2M ago
Arcutis announces new pooled subgroup analysis results from INTEGUMENT-1 trial
Premium
The Fly
Arcutis announces new pooled subgroup analysis results from INTEGUMENT-1 trial
3M ago
Arcutis Biotherapeutics (ARQT) Riding High on Psoriasis Treatment
PremiumMarket NewsArcutis Biotherapeutics (ARQT) Riding High on Psoriasis Treatment
4M ago
Arcutis Biotherapeutics initiated with a Buy at Jefferies
Premium
The Fly
Arcutis Biotherapeutics initiated with a Buy at Jefferies
4M ago
Arcutis jumps after Mizuho highlights ‘robust’ weekly script growth
Premium
The Fly
Arcutis jumps after Mizuho highlights ‘robust’ weekly script growth
4M ago
Arcutis enters ZORYVE co-promotion agreement with Kowa Pharmaceuticals
PremiumThe FlyArcutis enters ZORYVE co-promotion agreement with Kowa Pharmaceuticals
5M ago
Arcutis Biotherapeutics launches ZORYVE cream
Premium
The Fly
Arcutis Biotherapeutics launches ZORYVE cream
5M ago
Arcutis Biotherapeutics submits sNDA for ZORYVE foam to FDA
Premium
The Fly
Arcutis Biotherapeutics submits sNDA for ZORYVE foam to FDA
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100